Valérie David

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 127 citations

Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10‐year retrospective study in a French region (Brittany)

Daniel Siret, G. Bretaudeau, B. Branger et al. · Pediatric Pulmonology · 2003 · 93 citations

Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study

Muriel Le Bourgeois, Agnès Ferroni, Marianne Leruez‐Ville et al. · The Journal of Pediatrics · 2016 · 80 citations · Full text

Empyema Risk, Nonsteroidal Anti-inflammatory Drug, Antibiotics +10

Assessment of vaccination by a phase I<i>Coxiella burnetii</i>-inactivated vaccine in goat herds in clinical Q fever situation: 1

Renée de Cremoux, Élodie Rousset, Anne Touratier et al. · FEMS Immunology & Medical Microbiology · 2011 · 62 citations · Full text

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2 years of treatment with ivacaftor in a real-world setting

D. Hubert, Clémence Dehillotte, À. Munck et al. · Journal of Cystic Fibrosis · 2017 · 58 citations

Medicine, Pathology, Pulmonary Fibrosis +2